deltatrials

Obesity Trials in Gdynia, Poland

Conditions / Obesity / Gdynia, Poland

Obesity is a medical condition with active clinical research programs worldwide.

12 total trials for this combination

Showing top 10 of 12 trials

Trials

NCT ID Title Status Phase
NCT06858839 Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight ACTIVE_NOT_RECRUITING PHASE3
NCT05649137 A Research Study to See How Semaglutide Helps People With Excess Weight and Type 2 Diabetes Lose Weight COMPLETED
NCT06077864 A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT) ACTIVE_NOT_RECRUITING
NCT02019264 A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors COMPLETED PHASE4
NCT07037433 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity RECRUITING
NCT04788511 Research Study to Investigate How Well Semaglutide Works in People Living With Heart Failure and Obesity COMPLETED PHASE3
NCT07037459 Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity RECRUITING
NCT06131372 A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo COMPLETED PHASE2
NCT03574597 Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity COMPLETED PHASE3
NCT05646706 A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP) COMPLETED

Related Pages